LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Hospital de Galdakao - Usansolo
Galdácano, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (9)
2024
-
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance
European Neuropsychopharmacology
2022
-
Heart-brain synchronization breakdown in Parkinson’s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
2021
-
Contributions of sex, depression, and cognition on brain connectivity dynamics in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1
2019
-
The relationship between inflammatory bowel disease and Parkinson’s disease: true or fiction?
Scandinavian Journal of Gastroenterology
2018
-
Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson's disease
European Journal of Neurology, Vol. 25, Núm. 1, pp. 5-12
2017
-
Increased brain connectivity and activation after cognitive rehabilitation in Parkinson’s disease: a randomized controlled trial
Brain Imaging and Behavior, Vol. 11, Núm. 6, pp. 1640-1651
2016
-
One-year clinical experience of perampanel in Spain: A multicentre study of efficacy and tolerability
Epileptic Disorders, Vol. 18, Núm. 2, pp. 173-180
2015
-
Neuroanatomical correlates of theory of mind deficit in Parkinson's disease: A multimodal imaging study
PLoS ONE, Vol. 10, Núm. 11
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218